Skip to main content
. 2018 Nov 19;42(2):265–272. doi: 10.2337/dc18-1178

Figure 1.

Figure 1

Fasting insulin (A), fasting FFA (B), and Adipose-IR (C) (fasting insulin × fasting FFA) in normal-weight (NW) vs. obese (Ob) subjects with NGT vs. IGT vs. type 2 diabetes (T2D). #P < 0.05 after adjustment for sex, race, Tanner stage, BMI, and VAT.

HHS Vulnerability Disclosure